CNAPS.AI
Develops AI workflow automation platform connecting multiple AI models
UndisclosedSeed
Role not disclosedND
NAVER D2SF
Activity from announced rounds
Activity in this selectionFeb 28, 2026 · AI · Feb 1, 2026
NAVER D2SF is NAVER’s startup investment organization, identified through official materials for ImpriMed and NdotLight.
Recorded funding activity
ImpriMed combines live-cell drug testing with clinical data. NdotLight generates simulation-ready 3D data, while F4GE structures factory information for industrial buyers. The organization retains its identity separately from NAVER Ventures and the parent.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $5M 1 disclosed · full round size, not this investor’s share